Theradiag SA (ALTHE.PA) stock: key figures, P/E, revenue and dividend

Health Care · Health Care Equipment · France · ISIN FR0010120402

Price
0.74 EUR
Market cap
54.60 m EUR
P/E (2025)
–
P/S (2025)
46.04
Dividend yield
0.00 %
Net margin
-479.76 %
Return on equity (ROE)
219.86 %
Return on assets (ROA)
-45.48 %

Theradiag SA financials

Fiscal year20242025
Revenue830,000.00 EUR1.19 m EUR
Gross profit-7.18 m EUR-6.21 m EUR
Operating income-6.96 m EUR-6.37 m EUR
EBIT-6.74 m EUR-6.38 m EUR
Net income-5.76 m EUR-5.69 m EUR
Diluted EPS – continuing operations-0.12 EUR-0.10 EUR

Full history since 2001, charts and your own formulas

This page shows the last two fiscal years. After free sign-up you get the full income statement, balance sheet and cash flow, price and dividend charts, your own formula metrics and a stock screener covering more than 8,000 companies.

About Theradiag SA

Theraclion SA provides therapeutic ultrasound technology for seamless vein care. It offers SONOVEIN, a robotic solution for the non-invasive echotherapy treatment of varicose veins; ECHOPULSE, a robotic and non-invasive solution for the echotherapy treatment of thyroid nodules and breast fibroadenoma; and EPack, a disposable that is installed on the device before treatment to protect the patient's skin and optimize image quality. The company was incorporated in 2004 and is headquartered in Malakoff, France.

More stocks

All stocks →

Not investment advice. All data without warranty, price as of 29.10.2026. Details in the risk notice.